Fiche centre
Sir Charles Gairdner Hospital
Nedlands — Australia
Essais liés5clinical trials
VilleNedlandslocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06667908
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Penumbra System ® | Accident vasculaire cérébral | À vérifier | NCT07107022 | i-RISE — Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population With Acute Ischemic Stroke (AIS). | RECRUITING |
| Xolatryp | Maladie coronarienne | Phase 2 | NCT07362446 | PROTECT-MI — Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction | RECRUITING |
| Coronary and peripheral stents | Maladie coronarienne | À vérifier | NCT04573660 | AV-MDR — Abbott Vascular Medical Device Registry | RECRUITING |
| JNJ-90301900 | Cancer | Phase 2 | NCT06667908 | CONVERGE — A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC) | RECRUITING |
| Amivantamab | Cancer | Phase 3 | NCT04538664 | PAPILLON — A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions | ACTIVE_NOT_RECRUITING |